Biomarkers Driving Precision Medicine in Nonfunctioning Pituitary Neuroendocrine Tumors: A Systematic Review of Recent Literature
OncologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- The Journal of clinical endocrinology and metabolism
- Publicado em
- 17 mar 2026
- Citações
- 2
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Biomarkers Driving Precision Medicine in Nonfunctioning Pituitary Neuroendocrine Tumors: A Systematic Review of Recent Literature
Amalina Haydar Ali Tajuddin, Nur Firdaus Isa, Mohd Hamzah Mohd Nasir
Descritores MeSH
- Biomarkers, Tumor
- Pituitary Neoplasms
- Neuroendocrine Tumors
- Precision Medicine
- Epithelial-Mesenchymal Transition
- Prognosis
- Humans
Veja também
Estudos relacionados
- Protein-Based Predictive Biomarkers to Personalize Neoadjuvant Therapy for Bladder Cancer-A Systematic Review of the Current Status
- DNA methylation as a predictor of pituitary neuroendocrine tumour behaviour: A systematic review
- Adequacy criteria and reporting for prognostic and predictive profiling of biopsies from gastrointestinal neoplasia: A position paper from the Italian group of gastrointestinal pathologists, section of Italian society of anatomic pathology and cytology (GIPAD-SIAPeC-IAP)
- A bird's eye view on potential molecular prognostic markers in retinoblastoma: insights for precision oncology